This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
By binding the substance to a radiotracer, experts were able to improve the accuracy of identifying of these tumors by as much as 30% compared to the standard of care.
A new PET/CT radiotracer that detects insulinomas could eliminate the need for other diagnostic procedures in a vast majority of patients, according to a study published October 17 in the Journal of Nuclear Medicine. The finding is from a clinical trial that compared PET/CT imaging with gallium-68 (Ga-68) NODAGA-exendin-4 PET/CT with all routine imaging procedures for the localization of insulinomas.
BOSTON -- In a video interview at CMIMI 2024, Nina Kottler, MD, of Radiology Partners shares highlights from her keynote presentation on the clinical deployment of radiology AI. She reviews three key best practices and also offers some advice. Full coverage of Kottler's talk can also be found here.
Amidst rising cancer prevalence and soaring costs, new cancer technologies and innovations are emerging to support the early detection, treatment, and surveillance of cancer. Read this guide to understand how to evaluate these solutions for your employees and members – and to learn more about the current state of coverage, clinical and cost effectiveness, and impact on quality and outcomes.
ChatGPT-4 is reasonably accurate in identifying radiological terms on chest x-ray reports, according to research presented at the Conference on Machine Intelligence in Medical Imaging (CMIMI). A team led by Jad Alsheikh from Creighton University in Omaha, NE, also found that the large language model can account for variations in terminology, but its performance varies for less common terms.
ChatGPT-4 is reasonably accurate in identifying radiological terms on chest x-ray reports, according to research presented at the Conference on Machine Intelligence in Medical Imaging (CMIMI). A team led by Jad Alsheikh from Creighton University in Omaha, NE, also found that the large language model can account for variations in terminology, but its performance varies for less common terms.
Mammograms are a crucial diagnostic tool that helps doctors detect early signs of breast cancer and other breast-related issues. However, many patients have concerns about radiation exposure and the potential risks involved. The truth is mammograms are generally safe when used properly, and the amount of radiation you’re exposed to is minimal. Medical professionals take necessary precautions to ensure patient safety and modern imaging technology continues to minimize radiation levels.
GE HealthCare (GEHC) has launched AI Innovation Lab, an initiative intended to support its early-concept AI innovations. AI Innovation Lab will tackle the following five initial AI research projects: Crafting an approach that includes expertise from genomics, radiology, and pathology clinicians that could help physicians streamline clinical decision-making and offer patients more personalized care.
Time-dependent diffusion MRI-based microstructural mapping helps predict breast cancer molecular subtypes and treatment response in women with the disease, researchers have reported. A team led by Xiaoxia Wang of Chongqing University Cancer Hospital in China found that the technique outperformed apparent diffusion coefficient (ADC) measurements and a clinical-pathologic model when it came to predicting treatment response, with an area under the receiver operating curve (AUC) of 0.88 compared wit
Patient-centric scheduling can only be achieved through optimized radiology workflows, effective communications between staff and physicians, and, of course, through specialized schedulers. In this guide, we’ll take you through a step-by-step process to transform your radiology center into a high-performance hub of medical imaging.
A new PET scan reliably detects benign tumors in the pancreas, according to new research. Current scans often fail to detect these insulinomas, even though they cause symptoms due to low blood sugar levels. Once the tumor is found, surgery is possible.
BOSTON -- Specific instructions for ChatGPT-4 can improve the large language model’s performance in protocol prediction accuracy in radiology, suggest findings presented at the Conference on Machine Intelligence in Medical Imaging (CMIMI). In a poster presentation at the Society for Imaging Informatics in Medicine's (SIIM)-hosted gathering, a team led by Kartik Gupta from Western University in London, Ontario, Canada, found that a rules-based approach and custom prompting improved ChatGPT-4’s pr
A team of researchers has created a 3D atlas of developing mice brains, providing a more dynamic understanding of how the mammalian brain develops. This atlas provides a common reference and anatomical framework to help researchers understand brain development and study neurodevelopmental disorders.
BOSTON -- A unified deep-learning framework can identify and accurately describe parotid gland tumors (PGTs) on CT exams, a study presented October 21 at the Conference on Machine Intelligence in Medical Imaging (CMIMI) found. Researchers led by Wei Shao, PhD, from the University of California, Irvine observed high accuracy from a multi-stage pipeline combining a first-pass screening model with a subsequent focused segmentation model, which could help identify PGTs missed in real clinical workfl
About 40% of us will be diagnosed with cancer in our lifetime, and patients are getting younger. At the same time, the cost of treatment continues to rise, with employers spending 8.5% more on cancer care for each employee than they did last year. The best thing employers can do for their employees and business tomorrow is to invest in cancer detection and care today.
While you weren’t looking, a lot has been happening in the field of ultrasound! New technologies, new workflows, new best practices. Over just a few short years, the potential uses of ultrasound have grown exponentially, and that means exciting things for you and your imaging team. Join us as we take a look at the latest developments in ultrasound you may have missed, even if you’re working on equipment that’s just a couple years old.
Viz.ai has upgraded its software to include expanded lung disease software capabilities driven by natural language processing and imaging AI. The expanded capabilities will help clinicians evaluate electronic health record information and triage patients with suspected lung disease for further follow-up, the company said. They will be incorporated into what Viz.ai calls its "AI-powered care acceleration platform.
For segment-level coronary artery calcium (CAC) scoring, a deep learning model had an accuracy rate of 73 percent for assigning calcifications to coronary artery segments and achieved a micro-average specificity of 97.8 percent.
Nucleus RadioPharma plans to develop two new research and development and production facilities in Mesa, AZ, and Springhouse, PA. The Arizona building will be 53,000 sq ft and the Springhouse site will be 48,000 sq ft, the company said. It expects the new sites to create at least 50 new jobs in each location. The expansion will address two challenges: a shortage of development and manufacturing facilities and geographic limitations caused by the short half-life of many radiopharmaceuticals, acco
Discover how Color's comprehensive care solution is revolutionizing cancer screening adherence and knowledge. Through an in-depth case study, Color's unique approach to comprehensive cancer care has shown significant benefits in increasing screening rates and enhancing patient knowledge. Participants reported a 2-3x increase in adherence to screening guidelines over just 8 weeks, with 84% of participants increasing their familiarity with timing and frequency of cancer screening.
Designed for theranostic imaging applications, the AnyScan Trio SPECT/CT TheraMax scanner was recently unveiled at the annual meeting of the European Association of Nuclear Medicine (EANM).
tim.hodson Mon, 10/21/2024 - 10:17 Oct. 21, 2024 — Siemens Healthineers recently received Food and Drug Administration clearance for two new features in its syngo.PET Cortical Analysis software application that use positron emission tomography (PET) to measure protein deposits in the brain associated with Alzheimer’s disease. The first new feature,Centiloid scoring, standardizes the quantification of brain-amyloid plaque in PET scans across three commercially available beta-amyloid PET radiophar
tim.hodson Mon, 10/21/2024 - 15:14 Oct. 21, 2024 — Gesund.ai, the clinical AI validation company, has announced the open sourcing of a comprehensive library of evaluation methodologies and frameworks to help developers and users address AI performance and potential bias across patient cohorts for the FDA-regulated AI solutions on the market. As part of its mission to standardize AI validation, Gesund.ai also announced it has joined the Coalition for Health AI, after partnering with public and p
Explore the latest insights from the American Cancer Society's “Cancer Statistics 2024” report, which unveils multiple alarming trends in cancer data. Cancer is on the rise among young adults, and diagnoses for 6 of the 10 most common cancers are escalating. With over 2 million new cancer cases projected in the U.S. this year, employers face increased challenges when it comes to supporting employees.
Hologic has signed a definitive agreement to acquire Gynesonics for approximately USD 350 million, strengthening its portfolio of medical technologies.
A new PET scan has shown promise in reliably detecting benign tumors in the pancreas that cannot be detected by various imaging techniques such as CT, MRI, and PET scans.
The American College of Chest Physicians has published a new clinical guideline on endobronchial ultrasound-guided transbronchial needle aspiration that aims.
Clinical AI represents a paradox. While its potential to revolutionize patient care is undeniable (and increasingly being proven ), healthcare leaders remain acutely aware of the risks involved with implementation. A recent survey of 3,000 leaders from 14 countries further illustrated this point with 87% of respondents expressing concern about AI data bias widening health disparities.
As HR and Benefits leaders are in the midst of evaluating cancer care solutions and designing their requirements for vendors, it’s key to know what questions to ask to ensure the development of a truly comprehensive strategy: from prevention to diagnosis to treatment to survivorship. Getting to the right answers starts with asking the right questions: How can better access improve engagement?
Input your email to sign up, or if you already have an account, log in here!
Enter your email address to reset your password. A temporary password will be e‑mailed to you.
We organize all of the trending information in your field so you don't have to. Join 5,000 users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content